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Cationic Host Defense Peptides (HDPs) are endowed with a broad variety of activities, including direct 
antimicrobial properties and modulatory roles in the innate immune response. Even if it has been 
widely demonstrated that bacterial membrane represents the main target of peptide antimicrobial 
activity, the molecular mechanisms underlying membrane perturbation by HDPs have not been fully 
clarified yet. Recently, two cryptic HDPs have been identified in human apolipoprotein B and found 
to be endowed with a broad-spectrum antimicrobial activity, and with anti-biofilm, wound healing 
and immunomodulatory properties. Moreover, ApoB derived HDPs are able to synergistically act in 
combination with conventional antibiotics, while being not toxic for eukaryotic cells. Here, by using 
a multidisciplinary approach, including time killing curves, Zeta potential measurements, membrane 
permeabilization assays, electron microscopy analyses, and isothermal titration calorimetry studies, 
the antimicrobial effects of ApoB cryptides have been analysed on bacterial strains either susceptible 
or resistant to peptide toxicity. Intriguingly, it emerged that even if electrostatic interactions between 
negatively charged bacterial membranes and positively charged HDPs play a key role in mediating 
peptide toxicity, they are strongly influenced by the composition of negatively charged bacterial 
surfaces and by defined extracellular microenvironments.
Antimicrobial peptides (AMPs) are effectors of the innate immune system in a wide variety of species from the 
plant and animal kingdoms, including humans1. Although structurally different, most of these peptides fold into 
amphiphilic structures due to their short size (<50 amino acid residues), net positive charge and high content 
of hydrophobic residues2. Their activity against a wide range of microorganisms combined with their unique 
property of displaying few to no resistance effects3 allowed AMPs to gain great attention as promising and effec-
tive alternatives to conventional antibiotics, also against strains resistant to approved antibacterial agents4. Since 
these peptides are also able to modulate the immune response of host organisms, their efficiency is considerably 
enhanced. Because of this extension of functionalities, they have been more properly named “host defence pep-
tides” (HDPs)5,6. The key features that make HDPs antimicrobial are their cationic nature, their ability to bind 
to bacterial membranes and to adopt specific secondary structures in membrane environments7, an essential 
prerequisite to their attachment and insertion into bacterial membranes. HDPs have been found to kill bacteria 
by first associating with their negatively charged cell surfaces and subsequently disrupt their cell membranes via 
mechanisms that involve membrane thinning, formation of transient pores, or disruption of lipid matrix, which 
impairs barrier function of bacterial membranes8. Some HDPs are also able to pass through the lipid bilayer of the 
membrane to act on intracellular targets8. Furthermore, some HDPs preferentially attack septating bacterial cells 
where peptides have been found to be associated to the septum and the curved regions of the outer membrane9. 
Since most HDPs target the bacterial plasma membrane directly rather than through specific protein receptors10, 
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membrane phospholipid composition and net charge also play a key role in determining peptides antimicrobial 
activity11. Indeed, these parameters vary not only from bacterium to bacterium, but also as a response to chang-
ing environments12 and exposure to antimicrobial agents13. Peptide concentration also represents a further key 
parameter, with maximal antimicrobial activity reached only at peptide concentrations exceeding a threshold 
value14. Indeed, upon an initial electrostatic interaction between positively charged peptide molecules and nega-
tively charged lipids, peptides reach an appropriate local concentration, allowing their penetration into the hydro-
phobic core of the bilayer15,16. Membrane bilayer thickness also appears to have an effect on the ability of a peptide 
to bind to the membrane and, consequently, on the ability of a lipid bilayer to induce peptide secondary struc-
tures17,18. However, despite decades of research, novel structural and dynamic features of membrane-associated 
HDPs are continuously being discovered19 and the exact molecular mechanism underlying HDPs ability to per-
turb bacterial membranes still remains controversial. Here, we analyse the antimicrobial activity of two recently 
characterized HDPs20, identified in human apolipoprotin B by using a bioinformatics method developed by our 
research group21–25. It has been reported that several eukaryotic proteins, with functions not necessarily related 
to host defence, act as sources of “cryptic” bioactive peptides released upon proteolytic processing by bacterial 
and/or host proteases26–28. The two novel bioactive peptides analysed in the present study represent two variants 
of the HDP identified in human apolipoprotein B (residues 887–922), i.e. peptides ApoB887–923 and ApoB887–
911. These two HDPs, recombinantly produced in bacterial cells, have been here named r(P)ApoBL and r(P)
ApoBS because of the presence of a Pro residue becoming the N-terminus of the peptides released by the acidic 
cleavage of an Asp-Pro bond20. The primary structure of the two ApoB derived HDPs is reported in Fig. S1. 
Both recombinant peptides have been found to be endowed with antimicrobial, anti-biofilm, wound healing and 
immunomodulatory properties20. On the other hand, they have been found to be neither toxic for mammalian 
cells nor hemolytic towards murine red blood cells. Interestingly, ApoB derived peptides were also found to 
exert significant synergistic effects in combination with either conventional antibiotics or EDTA20. Noteworthy, 
bacterial strains found to be not responsive to ApoB derived peptides, such as S. aureus strains and P. aeruginosa 
ATCC 27853, appeared highly susceptible to selected combinations of peptides and antibiotics or EDTA20, thus 
opening interesting perspectives to the development of successful combination therapy approaches, that have a 
very low potential to induce resistance phenotype. Since the definition of the molecular bases of ApoB derived 
peptides biological activities could greatly contribute to the rational design of effective combinatorial therapeutic 
approaches, in the present paper, time killing curves, Zeta potential measurements, membrane permeabilization 
assays, isothermal titration calorimetry studies and morphological analyses by electron microscopy have been 
performed.
Results
Killing kinetics studies. It has been previously reported that ApoB derived peptides are effective on B. glo-
bigii TNO BM013 and P. aeruginosa PAO1 bacterial strains20, as shown in Table S1. Here, in order to analyse the 
kinetic of peptides bactericidal activity, we obtained kinetic killing curves by treating bacterial cells with increas-
ing concentrations of either r(P)ApoBL or r(P)ApoBS for different time intervals (0–180 min). The two bacterial 
strains have been selected as a prototype of Gram-positive (B. globigii TNO BM013) and Gram-negative (P. aerug-
inosa PAO1) strains susceptible to antimicrobial ApoB derived peptides. In all the experiments, chicken catheli-
cidin-2 (CATH-2), a known antimicrobial peptide from chicken29, was tested as a positive control (Fig. 1E,F). To 
perform the analyses, following the incubation with peptides, control and treated samples were serially diluted 
and plated on agar, in order to count bacterial colonies30. As reported in Fig. 1A,C, at the highest peptide con-
centrations tested (10–20 µM), B. globigii TNO BM013 cells were killed within 10–30 min. At the lowest peptide 
concentrations (1.25–2.5 µM), instead, the same effect was obtained within 120 min (Fig. 1A,C). When peptides 
were tested on P. aeruginosa PAO1, bacterial cells were killed within 30 minutes at the highest peptide concentra-
tions tested (10–20 µM), and within 120–180 minutes at lower peptide concentrations (2.5–5 µM) (Fig. 1B,D). In 
the case of CATH-2 control peptide, all the curves obtained appear perfectly superimposable, since all peptide 
concentrations tested were found to have the same effects. As a consequence, only the curves corresponding to 
the highest peptide concentration tested (20 µM) appear visible (Fig. 1E,F).
Zeta potential measurements of bacterial cells upon treatment with peptides. To evaluate ApoB 
derived peptides effects on bacterial membrane surface, Zeta potential (ζ) measurements were carried out. First 
of all, ζ values of control bacterial cells were determined over time (0–180 min) in NB 0.5X medium, in order to 
obtain the electrostatic potential at the shear plane of the bacteria in solution (Fig. S2). It was found that ζ did 
not vary throughout the incubation time in the case of all the strains tested, thus indicating their high stability. 
In detail, the average potential of untreated B. globigii TNO BM013, S. aureus MRSA WKZ-2, P. aeruginosa 
PAO1 and P. aeruginosa ATCC 27853 strains were found to be −33 ± 3, −28 ± 3, −23 ± 2, and −11 ± 2 mV, 
respectively (Fig. S2 and Table 1). The different values obtained for the various bacterial strains might be due to 
differences in membrane composition. Bacterial strains susceptible to antimicrobial ApoB derived peptides, i.e. 
B. globigii TNO BM013 and P. aeruginosa PAO1, were exposed to r(P)ApoBL or r(P)ApoBS at a concentration 
corresponding to their MIC values (Table S1). Upon treatment with each peptide, ζ was recorded at regular time 
intervals for 180 min. All the recorded ζ values are reported in Fig. S3. Values corresponding to the time point 
necessary to obtain complete cell death of treated bacterial cells on agar plates (30 min) have been reported for B. 
globigii TNO BM013 and P. aeruginosa PAO1 (both of them susceptible to antimicrobial peptides) in Fig. 2A,C, 
respectively. In Fig. 2B,D, instead, ζ values measured at the highest peptide concentration tested (40 µM) for 
S. aureus MRSA WKZ-2 and P. aeruginosa ATCC 27853 (both of them non-susceptible to antimicrobial pep-
tides) are reported. Upon incubation of B. globigii TNO BM013 with r(P)ApoBL or r(P)ApoBS, ζ was found to 
shift from −33 ± 3 mV to −11 ± 3 and −19 ± 3 mV, respectively (Fig. 2A and Table 1). This is indicative of the 
occurrence of electrostatic interactions between positively charged peptides and negatively charged bacterial 
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surfaces, which leads to a partial neutralization of bacterial surface charge. A similar behavior was also observed 
in the case of Gram-negative P. aeruginosa PAO1 bacterial strain upon treatment with r(P)ApoBL or r(P)ApoBS, 
since also in this case ζ shifted towards more positive values (Fig. 2C and Table 1). It is worth to highlight that, 
Figure 1. Time killing curves obtained by incubating B. globigii TNO BM013 (A,C,E) and P. aeruginosa PAO1 
(B,D,F) strains with increasing concentrations of r(P)ApoBL (A,B), r(P)ApoBS (C,D) and CATH-2 (E,F) 
peptides for different lengths of time. Data represent the mean ( ± standard deviation, SD) of at least three 
independent experiments, each one carried out with triplicate determinations. For all the experimental points, 
*P < 0.05, **P < 0.01, or ***P < 0.001 were obtained for control versus treated samples.
SAMPLE Z-POTENTIAL ± DS (mV)
B. globigii TNO BM013
Cells t0 −33 ± 3
Cells t30 min −29 ± 2
Cells + r(P)ApoBL t30 min −11 ± 3
Cells + r(P)ApoBS t30 min −19 ± 3
P. aeruginosa PAO1
Cells t0 −23 ± 2
Cells t30 min −23 ± 2
Cells + r(P)ApoBL t30 min −19 ± 3
Cells + r(P)ApoBS t30 min −17 ± 3
S. aureus MRSA WKZ−2
Cells t0 −28 ± 3
Cells t30 min −26 ± 2
Cells + r(P)ApoBL t30 min −4 ± 3
Cells + r(P)ApoBS t30 min −4 ± 3
P. aeruginosa ATCC 27853
Cells t0 −11 ± 2
Cells t30 min −10 ± 2
Cells + r(P)ApoBL t30 min −3 ± 2
Cells + r(P)ApoBS t30 min −3 ± 2
Peptides alone
r(P)ApoBL −3 ± 1
r(P)ApoBS −3 ± 1
Table 1. Zeta-potential values recorded for bacterial cells at time 0 and upon 30 min in the absence or in the 
presence of ApoB derived peptides; zeta-potential values of each peptide in solution are also reported.
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in the case of B. globigii TNO BM013 bacterial strain, a larger ζ shift was observed with respect to P. aeruginosa 
PAO1, as expected on the basis of its higher sensitivity to peptide toxicity. On the contrary, in the case of bacterial 
strains non-responsive to antimicrobial ApoB derived peptides, obtained signals were found to be almost com-
pletely superimposable to those recorded for the free peptide in solution at the same concentration (Fig. 2B,D, 
dashed lines), thus clearly indicating that only the signal attributable to the free peptide in solution was meas-
ured (Fig. 2B,D, dashed lines). This indicates that, in the case of non-responsive bacterial strains, no electrostatic 
interactions occur between bacterial surfaces and antimicrobial peptides. It is presumable that some extracellular 
factors or bacterial membrane composition might interfere with electrostatic interactions between negatively 
charged bacterial surfaces and positively charged peptides, and this ultimately makes peptides ineffective.
Membrane permeabilization assays. To evaluate the effect of ApoB derived peptides on bacterial 
membrane permeability, N-Phenyl-1-naphthylamine (NPN) fluorescent probe was used. As expected, NPN 
uptake was found to be negligible for untreated bacterial cells, characterized by intact cell surface (Table 2 and 
Fig. S4A,B). The spectrofluorometric assay was also performed upon treatment of bacterial strains with ApoB 
derived peptides for 30 min at 37 °C. Incubation time was selected on the basis of time killing curve data (Fig. 1). 
B. globigii TNO BM013 and P. aeruginosa PAO1 responsive strains were treated with peptide concentrations 
corresponding to previously determined MIC100 values20, reported in Table S1, whereas not responsive S. aureus 
MRSA WKZ-2 and P. aeruginosa ATCC 27853 strains were treated with 40 µM peptides for 30 min at 37 °C. As 
shown in Table 2, NPN uptake factor was found to be 1.4 ± 0.9 for control P. aeruginosa PAO1 cells, and increased 
to 8.9 ± 1.2 and 11.1 ± 2.0 upon treatment with r(P)ApoBL and r(P)ApoBS, respectively (Table 2). Similar results 
were obtained when responsive Gram-positive B. globigii TNO BM013 strain was tested. Indeed, NPN uptake 
factor was found to be 4.1 ± 0.9 for control cells and 7.8 ± 1.1 or 7.6 ± 1.0 for cells treated with r(P)ApoBL and 
r(P)ApoBS, respectively (Table 2). On the other hand, no significant variation in NPN uptake was detected when 
not responsive bacterial cells were treated with ApoB derived peptides (Table 2). As a positive control, bacterial 
strains under test were treated with increasing concentrations of polycationic antibiotic colistin (0.25–4 μg/mL) 
or glycopeptide antibiotic vancomycin (0.00156–0.250 μg/mL). In both cases, following treatment, NPN uptake 
was found to increase in a concentration dependent manner (Fig. S4A,B). Indeed, both antibiotics, although 
with different mechanisms, have been reported to ultimately cause membrane permeabilization31,32. Altogether, 
obtained results confirm the crucial role played by bacterial membrane as main target of ApoB derived peptides 
antimicrobial activity.
Figure 2. ApoB derived peptides effects on the Zeta potential of treated bacterial cells. Zeta potential values of 
B. globigii TNO BM013 (A) and P. aeruginosa PAO1 (C) bacterial strains were determined upon treatment with 
r(P)ApoBL or r(P)ApoBS peptides at a concentration corresponding to MIC100 values. Zeta potential values of 
bacterial strains not responsive to antimicrobial ApoB derived peptides, i.e. S. aureus MRSA WKZ-2 (B) and 
P. aeruginosa ATCC 27853 (D), were determined upon treatment with peptides at the highest concentration 
tested (40 µM) for 180 min. Dashed curves represent the Zeta potential values of ApoB derived peptides alone 
in bacterial culture medium (NB 0.5X). In the case of B. globigii TNO BM013 (A) and P. aeruginosa PAO1 (C) 
bacterial strains, a positive ζ shift is indicative of an interaction between bacterial cells and peptides. On the 
contrary, in the case of S. aureus MRSA WKZ-2 (B) and P. aeruginosa ATCC 27853 (D) bacterial strains, signals 
recorded upon treatment with peptides (continuous lines) are almost completely superimposable to those 
recorded for free peptide in culture medium at 40 µM (dashed lines), thus indicating absence of interactions 
between bacterial cells and peptides. Data represent the average of at least three independent experiments.
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Morphological alterations induced by ApoB derived peptides. To evaluate morphological altera-
tions of bacterial strains susceptible to antimicrobial ApoB derived peptides, transmission electron microscopy 
(TEM) analyses were performed. In the case of control bacterial cells, intact membranes, a homogeneous intra-
cellular distribution of DNA and ribosomes rich areas were observed (dark areas in Fig. 3). When bacterial cells 
were, instead, treated with increasing concentrations of r(P)ApoBL peptide, a progressive detachment of cell wall 
and cell lysis was observed in the case of Gram-positive B. globigii TNO BM013 (Fig. 3A). Similarly, in the case of 
Gram-negative P. aeruginosa PAO1, a progressive wrinkling of outer membrane, dissociation of membrane frag-
ments, permeabilization of outer and inner membranes and the leakage of electron dense material was detected 
(Fig. 3B). Moreover, in both cases, a complete alteration of intracellular morphology, with a decrease of cytoplasm 
density, was evaluated at the highest peptide concentrations tested (Fig. 3). Similar results were obtained when 
B. globigii TNO BM013 and P. aeruginosa PAO1 strains were treated with r(P)ApoBS peptide at a concentration 
of 5 and 20 µM, respectively (Fig. 4A,B). It is noteworthy that significant morphological alterations were already 
detected when peptides were tested at sub-MIC concentrations.
Furthermore, to analyse the surface of responsive bacterial cells upon treatment with antimicrobial ApoB 
derived peptides, scanning electron microscopy (SEM) analyses were also performed. In the absence of peptides, 
bacterial cells displayed smooth and intact surfaces (Figs 5 and 6). Preliminary occurrence of biofilm extracel-
lular matrix formation was also detected in the case of control P. aeruginosa PAO1 cells (Figs 5B and 6B). When 
bacterial cells were, instead, treated with peptides, bacterial surfaces appeared corrugated with some dimples, 
Samples
NPN uptake 
factor ± SD
B. globigii TNO BM013
Cells 4.1 ± 0.9
Cells + r(P)ApoBL t30 min 7.8 ± 1.1
Cells + r(P)ApoBS t30 min 7.6 ± 1.0
P. aeruginosa PAO1
Cells t0 1.4 ± 0.9
Cells + r(P)ApoBL t30 min 8.9 ± 1.2
Cells + r(P)ApoBS t30 min 11.1 ± 2.0
S. aureus MRSA WKZ-2
Cells t0 1.6 ± 0.5
Cells + r(P)ApoBL t30 min 0.7 ± 0.1
Cells + r(P)ApoBS t30 min 1.2 ± 0.1
P. aeruginosa ATCC 27853
Cells t0 0.2 ± 0.1
Cells + r(P)ApoBL t30 min 0.3 ± 0.1
Cells + r(P)ApoBS t30 min 0.5 ± 0.1
Table 2. NPN uptake factors determined upon incubation of bacterial cells in the presence or in the absence of 
ApoB derived peptides. Data represent the average of at least three independent experiments.
Figure 3. Morphological analyses of B. globigii TNO BM013 (A) and P. aeruginosa PAO1 (B) cells by TEM. 
Representative images are shown upon treatment of bacterial cells with increasing concentrations (0–80 μM) 
of r(P)ApoBL peptide. A total of 60 cells were analysed for each peptide concentration in two independent 
experiments. Bars 250, 500 or 1,000 nm.
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Figure 4. Morphological analyses of B. globigii TNO BM013 (A) and P. aeruginosa PAO1 (B) cells by 
TEM. Representative images are shown upon treatment of bacterial cells with r(P)ApoBS concentrations 
corresponding to sub-MIC values (5 μM and 20 μM for B. globigii TNO BM013 and P. aeruginosa PAO1 cells, 
respectively). A total of 60 cells were analysed for each sample in two independent experiments. Bars 250, 500 or 
1,000 nm.
Figure 5. Morphological analyses of B. globigii TNO BM013 (A) and P. aeruginosa PAO1 (B) cells by SEM. 
Representative images are shown upon treatment of bacterial cells with 40 µM r(P)ApoBL. A total of 60 cells 
were analysed for each sample in two independent experiments. Bars 2 or 4 µm.
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both in the case of B. globigii TNO BM013 and P. aeruginosa PAO1 strains (Figs 5 and 6). Even more interesting 
is the evidence that the treatment of B. globigii TNO BM013 cells with ApoB derived peptides induces cells to 
grow as long filaments (Figs 5A and 6A), probably as a consequence of septation block, thus strongly suggesting 
that these peptides act by ultimately inhibiting cell division. To monitor this phenomenon, experiments were 
also performed by incubating B. globigii TNO BM013 cells with increasing concentrations of either r(P)ApoBL 
or r(P)ApoBS peptide. Obtained results, reported in Figs S5 and S6, clearly indicate that both peptides induce a 
septation block even at concentrations significantly lower than MIC100 value. Moreover, obtained results support 
the evidence that peptides effects strongly depend on the features of bacterial strains under test. Indeed, when 
P. aeruginosa PAO1 cells were treated with 40 µM r(P)ApoBL (Fig. 5B) or 40 µM r(P)ApoBS peptide (Fig. 6B), no 
evidence of cell division block was detected. However, in both cases, a significantly lower cell density, indicative of 
a massive cell death, was revealed (Figs 5B and 6B). Moreover, in the case of all the treated samples, cell surfaces 
appeared irregular, corrugated, and withered (Figs 5 and 6), with some dimples and signs of cytoplasm leakage 
especially in the case of P. aeruginosa PAO1strain (Figs 5B and 6B).
Analysis of lipopolysaccharides (LPSs) isolated from P. aeruginosa ATCC 27853 and P. aerugi-
nosa PAO1 bacterial strains. We previously demonstrated, by Far UV-CD analyses, that r(P)ApoBL pep-
tide gradually assumes a defined structure in the presence of increasing concentrations of LPS, what suggests a 
direct binding of this peptide to LPS20. Here, to investigate the role played by LPS molecules in the efficacy or 
the inefficacy of ApoB derived peptides on Gram-negative bacterial strains, we extracted LPS molecules from 
P. aeruginosa ATCC 27853 and P. aeruginosa PAO1 bacteria. Afterwards, we analysed the interaction between 
ApoB derived peptides and the two purified LPS fractions by isothermal titration calorimetry (ITC) experiments. 
As shown in Fig. 7A, r(P)ApoBL and r(P)ApoBS peptides appear to bind to LPS molecules extracted from the 
two bacterial strains in a very similar fashion. Binding reactions were found to be all endothermic, thus indicat-
ing that they are driven by entropy rather than enthalpy. In the case of the binding of r(P)ApoBL peptide to the 
LPS extracted from P. aeruginosa PAO1, a dissociation constant (Kd) of 3.6 × 10−6 M was determined, with an 
entropy (ΔS) of 269 J/mol and a positive enthalpy (ΔH) of 51.1 KJ/mol (Table S2). Similar spectra and binding 
parameters were also obtained in the case of the interaction of r(P)ApoBS peptide with LPS molecules extracted 
from P. aeruginosa PA01 bacterial strain (Fig. 7A and Table S2). No significant differences were detected when 
the binding of both ApoB derived peptides to LPS molecules extracted from P. aeruginosa ATCC 27853 strain 
was analysed (Fig. 7A and Table S2). Altogether, obtained data indicate that both ApoB derived peptides are able 
to directly interact with LPS molecules extracted from the two bacterial strains, with no major differences in the 
binding of peptides to LPS molecules extracted from P. aeruginosa susceptible and not responsive bacterial strains 
(Fig. 7A and Table S2), at least in in vitro experiments and in the experimental conditions tested. To deepen on the 
role that LPS molecules might play in determining the different susceptibility of Gram-negative bacterial strains 
to ApoB derived peptides toxicity, we also performed a preliminary characterization of LPS molecules extracted 
from P. aeruginosa ATCC 27853 and P. aeruginosa PAO1 bacterial strains. To this purpose, LPSs extracted from 
dried bacterial cells by the PCP method were analysed by 14% DOC-PAGE electrophoresis and visualized by 
silver nitrate staining, that revealed a smooth LPS for both strains. Smooth LPS extracted from E. coli O55:B5 was 
used as a standard (data not shown). To define the glycosyl compositions of the intact LPSs, acetylated methyl 
glycosides were analysed by GC-MS. The monosaccharides were identified from their EI mass spectra and from 
Figure 6. Morphological analyses of B. globigii TNO BM013 (A) and P. aeruginosa PAO1 (B) cells by SEM. 
Representative images are shown upon treatment of bacterial cells with 40 µM r(P)ApoBS. A total of 60 cells 
were analysed for each sample in two independent experiments. Bars 2 or 4 µm.
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their GC column retention time by comparison with authentic standards. For both LPSs, rhamnose (Rha), glu-
cose (Glc), 2-amino-2-deoxy-D-galactopyranose (GalN), 2-amino-2-deoxy-D-glucopyranose (GlcN), and 
3-deoxy-D-manno-oct-2-ulosonic acid (Kdo) were found to be present (Fig. 7B,C). The occurrence of heptoses 
in both LPSs was displayed only upon a de-phosphorylation reaction obtained by HF treatment (data not shown). 
It is important to highlight the selective presence of 2-amino-2,6-dideoxy-D-galactopyranose (FucN) in P. aerug-
inosa PAO1 LPS, as indicated by the chromatogram (Fig. 7B). It is noteworthy that the majority of P. aeruginosa 
strains have been reported to co-express two chemically and distinct forms of LPS O-antigens: (i) a serotype con-
taining the O-antigen B-band and (ii) a common antigen referred to as O-antigen A-band. The chemical struc-
ture of the A-band from most of the sero-types was shown to be a linear α-D-rhamnan33; instead, the chemical 
structure of the B-band was reported to contain two derivatives of the 2,3-diamino-2,3-dideoxy-D-mannuronic 
acid (Man2N3NA) and FucN34. Our results suggest the absence of the B-band in the case of P. aeruginosa ATCC 
27853 strain. This feature might be responsible for the different response of the two Gram-negative strains under 
test to ApoB derived peptides.
Discussion
The healthcare burden associated to the increasing emergence of microorganisms resistant to multiple antimicro-
bial compounds has accelerated in recent years, and alternative weapons are urgently needed. However, despite 
huge efforts, the discovery, development, manufacture and marketing of new antibiotics has significantly slowed 
down in the past 30 years, whereas the clinical and economic impact of resistance is alarmingly rising. Although 
the scientific difficulty in identifying novel antibiotics may be increasing, as microbes become resistant to an 
ever-increasing array of treatments and, concomitantly, the identification of novel targets is challenging, the main 
explanation is that investments made by large pharmaceutical companies did not lead to profitable products35. In 
this scenario, naturally occurring Host Defense Peptides (HDPs) are gaining great attention. Indeed, being essen-
tial constituents of innate immunity, they represent promising lead structures to develop antibiotics against 
Gram-negative and Gram-positive bacteria, including strains resistant to approved antibacterial agents4. We 
recently characterized novel human HDPs identified by a bioinformatics approach in human ApoB20,21, and 
demonstrated that the two recombinant ApoB derived HDPs are endowed with a broad-spectrum anti-microbial 
activity, and with anti-biofilm, wound healing and immunomodulatory properties20. On the other hand, they 
have been found to be neither toxic nor hemolytic towards eukaryotic cells, what opens interesting perspectives 
to their therapeutic applicability20. However, it should be emphasized that ApoB derived AMPs were found to be 
antimicrobial towards four out of eight strains tested, i.e. E. coli ATCC 25922, P. aeruginosa PAO1, B. globigii TNO 
BM013, and B. licheniformis ATCC 21424, with MIC100 values comprised between 1.25 and 20 µM, indicating that 
they are effective on both Gram-negative and Gram-positive bacterial strains20. On the other hand, they were 
found to be ineffective towards P. aeruginosa ATCC 27853, methicillin-resistant S. aureus (MRSA WKZ-2), and 
S. aureus ATCC 2921320. However, when peptides were tested in combination with conventional antibiotics or 
EDTA, remarkable synergistic effects were detected20. Indeed, bacterial strains found to be not responsive to 
ApoB derived AMPs toxicity, such as S. aureus strains and P. aeruginosa ATCC 27853, were found to be highly 
susceptible to combinations of ApoB derived peptides with antibiotics or EDTA20. This paves the way to the devel-
opment of successful combination therapy approaches, that have a very low potential to induce resistance pheno-
type. Since the definition of the molecular bases of ApoB derived peptides antimicrobial activity could be crucial 
for the design of effective combinatorial therapeutic approaches, the mechanism of action of the two ApoB 
derived AMPs has been here investigated by selecting four bacterial strains as prototypes of Gram-positive and 
Figure 7. Analysis of the binding between ApoB derived peptides and LPSs extracted from P. aeruginosa PAO1 
and P. aeruginosa ATCC 27853 bacterial strains by isothermal titration calorimetry (ITC) (A). The negative 
peaks indicate heat requirement for binding (endothermic), and are indicative of an entropy-driven binding 
reaction. (a) Binding of r(P)ApoBL peptide to LPS from P. aeruginosa PAO1; (b) binding of r(P)ApoBL peptide 
to LPS from P. aeruginosa ATCC 27853; (c) binding of r(P)ApoBS peptide to LPS from P. aeruginosa PAO1; (d) 
binding of r(P)ApoBS peptide to LPS from P. aeruginosa ATCC 27853. Chromatograms of acetylated methyl 
glycosides of LPSs extracted from P. aeruginosa PAO1 (B), and from P. aeruginosa ATCC 27853 (C).
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Gram-negative strains susceptible or resistant to antimicrobial ApoB derived peptides. First of all, we analysed the 
kinetic of peptides bactericidal activity, and demonstrated that, at the highest peptide concentrations tested (10–
20 µM), susceptible bacterial cells (B. globigii TNO BM013 and P. aeruginosa PAO1cells) were killed within a very 
short time interval, i.e. 30 min. This evidence is in perfect agreement with data collected by measuring Zeta poten-
tial values upon incubation of susceptible bacterial cells with ApoB derived peptides tested at concentrations 
corresponding to previously determined MIC100 values. Indeed, in all the cases, a significant increase of Zeta 
potential values was detected, what is indicative of the occurrence of electrostatic interactions between positively 
charged peptides and negatively charged bacterial surfaces, with a consequent neutralization of bacterial surface. 
Interestingly, a greater variation in Zeta potential values was detected in the case of the strain characterized by the 
highest sensitivity to peptide toxicity, i.e. B. globigii TNO BM013. This might be indicative of a higher electrostatic 
affinity between cationic peptides and negatively charged bacterial surface. Indeed, it has been reported that bac-
terial membrane surface neutralization is a key event mediating the anti-microbial activity of several peptides36, 
with Zeta potential alteration generally preceding membrane permeabilization leading to cell death36. In perfect 
agreement with this finding, a significant increase of NPN uptake factor was selectively detected upon treatment 
of susceptible bacterial strains with ApoB derived peptides, thus strongly supporting the evidence that Zeta 
potential increase precedes membrane permeabilization, and confirming the crucial role played by bacterial 
membrane as main target of ApoB derived peptides antimicrobial activity. Moreover, in the case of B. globigii 
TNO BM013 susceptible bacterial strain, Zeta potential increase and membrane permeabilization is also accom-
panied by a septation block, as indicated by electron microscopy analyses performed at different time intervals 
and upon treatment with increasing ApoB derived peptides concentrations. These findings are in perfect agree-
ment with a recent report indicating that E. coli treatment with antimicrobial peptides causes cells to filament 
through a division block controlled by the PhoQ/PhoP signaling pathway37. Bacterial cell filamentation, here 
observed by electron microscopy analyses, might be a result of DNA replication inhibition, SOS induction, chro-
mosome segregation, or failure of septation process38. It has been previously reported that treatment of E. coli with 
the antimicrobial peptide microcin J25 causes cells to filament, with a consequent inhibition of cell division pro-
cesses through a non-SOS-dependent mechanism mediating a bacteriostatic mode of action39. Similarly, E. coli 
cells treated with diptericin showed a significantly elongated morphology, indicating that this peptide may affect 
cell targets involved in cell division to induce cell death, as suggested by its selective activity on actively growing 
E. coli cells40. Also human defensin 5 (HD5) was found to induce extensive cell elongation, with a consequent 
disruption of cell division events41. Interestingly, in agreement with our findings, such treatment outcomes were 
observed only upon treatment of Gram-negative bacteria with HD5, thus suggesting a common inhibitory activ-
ity depending on specific features of bacterial strains under test. Also in the case of ApoB derived peptides, effects 
appear to strongly depend on specific properties of analysed bacterial strains. Indeed, in the case of Gram-negative 
P. aeruginosa PAO1 strain, no signs of cell division block were detected upon treatment with ApoB derived pep-
tides, although significant alterations of cell morphology, with irregular and corrugated cell surfaces, signs of 
cytoplasm leakage and cell death, were detected. It has also to be emphasized that two out of four bacterial strains 
selected in the present study appear resistant to ApoB derived peptides antimicrobial activity, although they are 
characterized by negatively charged surfaces, as indicated by Zeta potential values determinations. In particular, 
in the case of Gram-positive B. globigii TNO BM013 and S. aureus MRSA WKZ-2 bacterial strains, Zeta potential 
values have been found to be −33 ± 3 and −28 ± 3, respectively, but only B. globigii TNO BM013 cells were found 
to be susceptible to ApoB derived peptides antimicrobial activity. In the case of Gram-negative P. aeruginosa 
PAO1 and P. aeruginosa ATCC 27853 strains, instead, Zeta potential values were found to be very different, i.e. 
−23 ± 2 and −11 ± 2 mV, respectively. It is plausible that this dissimilarity reflects differences in bacterial mem-
brane composition ultimately affecting peptide ability to interfere with bacterial cell viability. Since no significant 
effects on Zeta potential values were detected in the case of resistant bacterial cells treated with ApoB derived 
peptides, it has been hypothesized a failure of electrostatic interactions between negatively charged bacterial 
surfaces and positively charged peptides, with a consequent counteraction of ApoB derived peptides antimicro-
bial activity. Indeed, it has been extensively reported that electrostatic interactions play a pivotal role in the cell 
killing process mediated by antimicrobial peptides42. Based on obtained results, it has been hypothesized that 
some extracellular factors or bacterial membrane composition might interfere with electrostatic interactions 
between peptides and bacterial surfaces in the case of resistant bacterial cells. Since previous analyses by Far 
UV-CD suggested a direct binding of r(P)ApoBL peptide to bacterial LPS20, experiments were here performed to 
verify whether ApoB derived peptides are able to directly interact with LPS molecules extracted from P. aerugi-
nosa PAO1 and P. aeruginosa ATCC 27853 bacterial strains. Analyses, performed by isothermal titration calorim-
etry (ITC), indicated that both ApoB derived peptides are able to directly interact with LPS molecules extracted 
from the two bacterial strains, with no significant differences, at least when peptide binding to LPS molecules is 
tested in in vitro experiments. However, it has to be considered that, in physiological conditions, where up to 
100,000 molecules of LPS are located at the surface of one single Gram-negative bacterium43, several factors, such 
as membrane composition or extracellular microenvironment, might interfere with peptide binding to exposed 
LPS molecules. Based on this, we also performed a preliminary characterization of LPS molecules extracted from 
P. aeruginosa PAO1 and P. aeruginosa ATCC 27853 bacterial strains, in order to evaluate whether differences in 
LPS structures might be responsible for the efficacy or the inefficacy of ApoB derived peptides on Gram-negative 
bacterial strains. Performed analyses indicated the selective presence of 2-amino-2,6-dideoxy-D-galactopyranose 
(FucN) in the LPS of susceptible P. aeruginosa PAO1 bacterial strain, whereas LPS B-band was found to be absent 
in the case of resistant P. aeruginosa ATCC 27853 strain. Since the B-band is reported to display negative charges, 
such as those of the Man2N3NA residues34, electrostatic interactions between positively charged ApoB derived 
peptides and LPS molecules exposed on P. aeruginosa PAO1 bacteria might involve these monosaccharides. 
Instead, the sole presence of the hydrophobic rhamnan chain (A-band) in the LPS of resistant P. aeruginosa ATCC 
27853 strain could be responsible for the failure of the electrostatic interactions between peptides and bacterial 
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surfaces. This might be one of the key factors responsible for the different response of the two Gram-negative 
bacterial strains to ApoB derived peptides toxicity.
Altogether, collected results indicate that ApoB derived peptides exert their antimicrobial activity by mainly 
targeting bacterial membrane and subsequently affecting intracellular molecules and/or processes, such as cell 
division (Fig. 8). Obtained findings also strongly indicate that an interference with electrostatic interactions 
between negatively charged bacterial surfaces and positively charged peptides, probably due to extracellular 
microenvironment or bacterial membrane composition, might counteract ApoB derived peptides antimicrobial 
activity (Fig. 8).
Materials and Methods
Materials. All the reagents were purchase from Sigma-Aldrich (Milan, Italy), unless differently specified. 
Chicken cathelicidin-2 (CATH-2) peptide was obtained from CPC Scientific Inc. (Sunnyvale, USA).
Recombinant production of ApoB derived peptides. Expression and isolation of recombinant pep-
tides was carried out as previously described20 with the only exception of a final gel-filtration step, that was added 
in order to remove salts used along the purification process and that tend to attach to the peptides, as previously 
reported44,45.
Bacterial strains and growth conditions. Methicillin-resistant Staphylococcus aureus (MRSA WKZ-2), 
Bacillus globigii TNO BM013, Pseudomonas aeruginosa ATCC 27853, and Pseudomonas aeruginosa PAO1 bacte-
rial strains were grown as previously described20.
Anti-microbial activity assay. To test the anti-microbial activity of ApoB derived peptides, previously 
described experimental procedure was used20. MIC100 values correspond to the lowest concentration of peptide 
associated to no detectable bacterial growth.
Killing kinetic studies. To kinetically analyse bacterial killing by ApoB derived peptides, experiments were 
performed on B. globigii TNO BM013 and P. aeruginosa PAO1 strains as previously described20.
Zeta potential measurements of bacterial cells in the presence of ApoB derived peptides. To 
perform analyses, bacteria were grown over-night in MHB medium, then diluted in fresh MHB, and incubated 
at 37 °C until logarithmic phase of growth was reached. Bacteria were then diluted to 4 × 106 CFU/mL in a final 
volume of 5 mL of NB 0.5X, and mixed with the peptide under test (1:1 v/v). In the case of bacterial strains sus-
ceptible to antimicrobial ApoB derived peptides, r(P)ApoBL and r(P)ApoBS were tested at concentrations corre-
sponding to MIC100 values. In the case of not responsive strains, instead, only the highest peptide concentration 
was tested (40 µM). At defined time intervals (0–180 min), Zeta potential values were determined. Zeta potential 
Figure 8. Schematic representation of the main experimental evidence herein collected.
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measurements of control samples were carried out in NB 0.5X pH 7.4. To test different peptide concentrations, 
serial dilutions were performed, in order to mix bacteria and peptides at a ratio of 1:1 v/v. The Zeta potential of 
bacterial cells was determined at 25 °C from the mean of 3 independent measurements (30 runs each), in the 
absence and in the presence of different peptide concentrations. Zeta potential values were obtained by phase 
analysis light scattering (PALS) in a Zetasizer Nano ZS 90 device (Malvern, Worcestershire, UK), equipped with 
Helium–Neon laser (633 nm) as a source of light, with the detection at 173 degree scattering angle at room tem-
perature (25 °C), using disposable Zeta cells with gold electrodes. Values of viscosity and refractive index were set 
to 0.8872 cP and 1.330, respectively.
NPN uptake assay. NPN uptake assays were carried out by following the previously described experimental 
procedure46. To do this, 1-N-phenylnaphthylamine (NPN) was diluted to 1 mM in 5 mM HEPES buffer pH 7.2. 
Control wells were prepared as follows: (i) buffer alone (1 mL); (ii) buffer (1 mL) and NPN (2 µL); (iii) bacteria 
in buffer (1 mL); (iv) bacteria in buffer (1 mL), NPN (2 µL). Antibiotics or peptides were mixed with bacterial 
suspension in Eppendorf tubes for 2 and 30 min, respectively, and then transferred into cuvettes. NPN was added 
immediately before the measurement of fluorescence; the values were recorded within 3 min. Fluorescence emis-
sion was detected at 420 nm upon excitation at 340 nm by using a PerkinElmer LS-55 luminescence spectrometer 
(Waltham, MA, USA). Each assay was performed at least three times. The results are expressed as NPN uptake 
factors, calculated by subtracting background, i.e. the value obtained in the absence of NPN.
Transmission electron microscopy. Bactericidal effects of ApoB derived peptides were also investigated 
by transmission electron microscopy (TEM) analyses, which required higher bacterial cell densities (2 × 108 
CFU/mL). For this reason, additional colony count assays were performed to determine ApoB derived peptides 
MIC100 values at this bacterial cell density. In the case of both peptides, a MIC100 value of about 80 μM was deter-
mined. To perform analyses, B. globigii TNO BM013 and P. aeruginosa PAO1 strains were incubated with increas-
ing concentrations of peptides (0–80 μM) for 3 hrs at 37 °C. Samples were then fixed with 2% glutaraldehyde 
(Polysciences, Eppelheim, Germany) in 5 mM CaCl2, 10 mM MgCl2 (both Merck, Darmstadt, Germany) in 0.1 M 
sodium cacodylate buffer pH 7.4 over-night at 4 °C. Bacteria treatment with peptides was stopped by adding 
the fixative and keeping the cells over-night at 4 °C. Cells were then washed 3 times by incubation in sodium 
cacodylate buffer for 10 min and embedded in 2% low-melting point agarose v/v. Cells were then post-fixed with 
4% osmium tetroxide (Electron Microscopy Sciences, EMS, Hatfield, USA) and 1.5% K4Fe(CN)6–3H2O (Merck, 
Darmstadt, Germany) in distilled water for 2 hrs at 4 °C. Upon cell washing with distilled water (5 times for 
10 min), cells were incubated in 0.5% uranylacetate (EMS, Hatfield, USA) for 1 hr at 4 °C. After further washing 
with distilled water (3 times for 10 min), samples were embedded in Epon resin and ultrathin sections (50 nm) 
of each block were prepared by using a Leica UCT ultramicrotome (Leica, Vienna, Austria). Obtained sections 
were stained with uranyl acetate and lead citrate by using the Leica AC20 system (Leica, Vienna, Austria). TEM 
images have been acquired in bright field mode using a Philips EM 208 S transmission electron microscope with 
an accelerating voltage of 80 kV.
Scanning electron microscopy. Bacterial cells in exponential growth phase were grown for 3 hrs in NB 
0.5X in microfuge tubes in the absence or in the presence of ApoB derived peptides. Also in this case, high bac-
terial cell densities were required (2 × 108 CFU/mL) for the analysis, and it should be underlined that, in these 
experimental conditions, peptides MIC100 value was found to be about 80 μM. To perform scanning electron 
microscopy (SEM) analyses, B. globigii TNO BM013 and P. aeruginosa PAO1 strains were incubated with 40 μM 
peptides for 3 hrs at 37 °C. Following incubation, bacterial cells were centrifuged at 10,000 rpm at 4 °C and fixed 
in 2.5% glutaraldehyde. Following over-night incubation, bacterial cells were washed three times in distilled water 
(dH2O) and then dehydrated with a graded ethanol series: 25% ethanol (1 × 10 min); 50% ethanol (1 × 10 min); 
75% ethanol (1 × 10 min); 95% ethanol (1 × 10 min); 100% anhydrous ethanol (3 × 30 min). Bacterial cells depos-
ited onto glass substrate were first sputter coated with a thin layer of Au-Pd (Sputter Coater Denton Vacuum Desk 
V) to allow subsequent morphological characterization using a FEI Nova NanoSEM 450 at an accelerating voltage 
of 5 kV with Everhart Thornley Detector (ETD) and Through Lens Detector (TLD) at high magnification.
Lipopolysaccharide (LPS) isolation, purification and characterization. Dried cells from P. aerugi-
nosa PAO1 (1 g) and P. aeruginosa ATCC 27853 (0.9 g) were extracted by PCP method, i.e. by using phenol/chlo-
roform/petroleum ether (2:5:8 v:v:v)47. The yields of extracted LPS was found to be 9% and 5% for P. aeruginosa 
PAO 1 and P. aeruginosa ATCC 27853, respectively. Both extracts were analysed by 14% DOC-PAGE, that was 
performed by using Laemmli procedure48,49 and sodium deoxycholate (DOC) as detergent. LPS bands were vis-
ualized by silver staining as described previously50. The glycosyl analysis was performed as previously reported51. 
Briefly, LPS samples (0.5 mg) were mixed with 1 mL of HCl/CH3OH, subjected to methanolysis for 16 hrs at 
80 °C, and then acetylated. Simultaneously, another sample of both native LPSs (0.5 mg) was firstly treated with 
HF (48%; 100 μL) and then subjected to methanolysis and acetylation. Finally, all the acetylated methyl glycosides 
(MGA) were analysed on an Agilent 7820 A GC System-5977B MSD spectrometer equipped with the automatic 
injector 7693A and a Zebron ZB-5 capillary column (Phenomenex, Toornace, CA, USA; fow rate 1 mL/min; He 
as carrier gas). MGA were analysed using the following temperature program: 140 °C for 3 min, 140 °C → 240 °C 
at 3 °C/min.
Isothermal titration calorimetry. Interaction between ApoB derived peptides and LPS molecules 
extracted from P. aeruginosa PAO1 or P. aeruginosa ATCC 27853 bacterial strains was tested by isothermal titra-
tion calorimetry (ITC) experiments, which were carried out on a Low Volume NanoITC (TA instruments, Waters 
LLC, New Castle, USA) at 37 °C. To this purpose, LPS molecules were diluted to 0.5 mg/mL in 50% phosphate 
buffer (PBS), and vortexed for 5 min. Afterwards 190 µL of LPS suspension were added to the cell chamber. The 
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syringe was then filled with 50 µL of 266 µM peptide solutions in 50% PBS. Titrations were incremental with 2 µL 
injections at 300 seconds intervals. Control spectra, obtained by injection of the same amount of each peptide in 
buffer solution, were subtracted to correct for heat production upon peptide dilution. Collected data were ana-
lyzed by using Nano Analyze software (TA instruments, Waters LLC, New Castle, USA).
Statistical analysis. Statistical analysis was performed using a Student’s t-Test. Significant differences were 
indicated as *(P < 0.05), **(P < 0.01) or ***(P < 0.001).
Data Availability
All the data supporting the conclusions have been included within the article.
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